CLIN.L - Clinigen Group Plc

LSE - LSE Delayed price. Currency in GBp
1,050.00
+47.00 (+4.69%)
At close: 4:36PM GMT
Stock chart is not supported by your current browser
Previous close1,003.00
Open1,016.00
Bid0.00 x 384900
Ask1,200.00 x 30000
Day's range1,006.00 - 1,054.00
52-week range751.50 - 1,187.00
Volume989,662
Avg. volume435,749
Market cap1.284B
BetaN/A
PE ratio (TTM)328.12
EPS (TTM)3.20
Earnings date13 Mar 2018 - 19 Mar 2018
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est1,267.60
  • 2 multi-bagging growth stocks I’d buy for 2018
    Fool.co.uk2 days ago

    2 multi-bagging growth stocks I’d buy for 2018

    It looks like 2018 could be a great year for growth investors. Here are two high-flying stocks for you to check out.

  • Business Wire2 months ago

    Clinigen Registers Garsun® (artesunate for injection) in South Africa for the Treatment of Patients with Severe Malaria

    Clinigen Group plc (AIM: CLIN, ‘Clinigen’ or the ‘Group’), the global pharmaceutical and services company, announces that it has registered Garsun® (artesunate for injection) in South Africa. Equity Pharmaceutical (Pty) Ltd, a division of Clinigen, will be the Holder of the Certificate of Registration. Garsun® is an innovative medicine indicated for the treatment of severe malaria, specifically caused by the parasite Plasmodium falciparum, in both adults and children.

  • PR Newswire2 months ago

    Neuberger Berman Group LLC - Form 8.3 - Clinigen Group PLC

    FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION ...

  • Business Wire3 months ago

    Form 8.3 - Clinigen Group Plc

    LONDON--(BUSINESSWIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) ...

  • PR Newswire3 months ago

    Miton Group Plc - Form 8.3 - Clinigen Group Plc

    FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION ...

  • Business Wire3 months ago

    Form 8.3 - Clinigen Group Plc

    LONDON--(BUSINESSWIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) ...

  • Business Wire3 months ago

    Form 8.3 - Clinigen Group Plc

    LONDON--(BUSINESSWIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) ...

  • PR Newswire3 months ago

    Neuberger Berman Group LLC - Form 8.3 - Clinigen Group PLC

    FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION ...

  • Business Wire3 months ago

    Form 8.3 - Clinigen Group PLC

    LONDON--(BUSINESSWIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) ...

  • Business Wire3 months ago

    Form 8.3 - Clinigen Group plc

    LONDON--(BUSINESSWIRE)-- FORM 8.3 PUBLIC DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full ...

  • Business Wire3 months ago

    Clinigen Acquires Japan’s Largest Supplier of Unlicensed Medicines

    BURTON-ON-TRENT, England--(BUSINESSWIRE)-- Clinigen Group plc (AIM: CLIN, ‘Clinigen’ or the ‘Group’), the global pharmaceutical and services company, has today acquired International Medical Management ...

  • Business Wire3 months ago

    Clinigen Acquires Japan’s Largest Supplier of Unlicensed Medicines

    Clinigen Group plc , the global pharmaceutical and services company, has today acquired International Medical Management Corporation , Japan’s largest supplier of unlicensed medicines, for an undisclosed sum.

  • Business Wire3 months ago

    Form 8.3 - Clinigen Group plc

    LONDON--(BUSINESSWIRE)-- Form 8.3 August 2016 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover ...

  • Business Wire3 months ago

    Form 8.3 - Clinigen Group Plc

    LONDON--(BUSINESSWIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) ...

  • Business Wire3 months ago

    Form 8.3 - Clinigen Group Plc

    LONDON--(BUSINESSWIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) ...

  • Business Wire3 months ago

    Form 8.3 - Clinigen Group PLC

    LONDON--(BUSINESSWIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) ...

  • PR Newswire3 months ago

    Neuberger Berman Group LLC - Form 8.3 - Clinigen Group PLC

    FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION ...

  • Business Wire3 months ago

    Form 8.3 - Clinigen Group PLC

    LONDON--(BUSINESSWIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) ...

  • PR Newswire3 months ago

    Neuberger Berman Group LLC - Form 8.3 - Clinigen Group PLC

    FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION ...

  • PR Newswire3 months ago

    Neuberger Berman Group LLC - Form 8.3 - Clinigen Group PLC

    FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION ...

  • Business Wire3 months ago

    Form 8.3 - Clinigen Group plc

    LONDON--(BUSINESSWIRE)-- FORM 8.3 PUBLIC DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full ...

  • PR Newswire3 months ago

    Neuberger Berman Group LLC - Form 8.3 - Clinigen Group PLC)

    FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION ...

  • PR Newswire3 months ago

    Neuberger Berman Group LLC - Form 8.3 - Clinigen Group PLC

    FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION ...

  • Business Wire4 months ago

    Form 8.3 - Clinigen Group PLC

    LONDON--(BUSINESSWIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) ...

  • PR Newswire4 months ago

    Neuberger Berman Group LLC - Form 8.3 - Clinigen Group PLC

    FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION ...

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes